A 
Align Technology ALGN · USD
Health Care · Health Care Equipment & Supplies · US listing · 🇺🇸 United States
S&P 500
174.26
+4.98%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$4.03bn
FY2016FY2025
Net income
$410.4m
FY2016FY2025
Free cash flow
$490.8m
FY2016FY2025
Shareholders' equity
$4.05bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.03bn | $4.00bn | $3.86bn | $3.73bn | $3.95bn | $2.47bn | $2.41bn | $1.97bn | $1.47bn | $1.08bn |
| Gross profit | $2.76bn | $2.80bn | $2.71bn | $2.63bn | $2.94bn | $1.76bn | $1.74bn | $1.45bn | $1.12bn | $815.3m |
| Research and development | $369.9m | $364.2m | $346.8m | $305.3m | $250.3m | $175.3m | $157.4m | $128.9m | $97.6m | $75.7m |
| Operating income | $616.2m | $607.6m | $643.3m | $642.6m | $976.4m | $387.2m | $542.5m | $466.6m | $353.6m | $248.9m |
| Net income | $410.4m | $421.4m | $445.1m | $361.6m | $772.0m | $1.78bn | $442.8m | $400.2m | $231.4m | $189.7m |
| Diluted earnings per share | 5.72 | 5.66 | 5.87 | 4.65 | 9.72 | 22.34 | 5.60 | 4.94 | 2.83 | 2.33 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $6.23bn | $6.21bn | $6.08bn | $5.95bn | $5.94bn | $4.83bn | $2.50bn | $2.05bn | $1.78bn | $1.40bn |
| Cash and short-term investments | $1.09bn | $1.04bn | $972.7m | $999.6m | $1.17bn | $960.8m | $868.6m | $735.4m | $721.5m | $640.3m |
| Total liabilities | $2.18bn | $2.36bn | $2.45bn | $2.35bn | $2.32bn | $1.60bn | $1.15bn | $799.6m | $627.5m | $400.8m |
| Debt | $31.9m | — | — | — | — | — | — | — | — | — |
| Shareholders' equity | $4.05bn | $3.85bn | $3.63bn | $3.60bn | $3.62bn | $3.23bn | $1.35bn | $1.25bn | $1.15bn | $995.4m |
| Shares outstanding | 72m | 74m | 76m | 78m | 79m | 80m | 79m | 81m | 82m | 82m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $593.2m | $738.2m | $785.8m | $568.7m | $1.17bn | $662.2m | $747.3m | $554.7m | $438.5m | $247.7m |
| Capital spending | −$102.4m | −$115.6m | −$177.7m | −$291.9m | −$401.1m | −$154.9m | −$149.7m | −$223.3m | −$195.7m | −$70.6m |
| Free cash flow | $490.8m | $622.7m | $608.1m | $276.8m | $771.4m | $507.3m | $597.6m | $331.4m | $242.8m | $177.1m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.06bn | $1.04bn | $1.05bn | $995.7m | $1.01bn | $979.3m | $995.2m | $977.9m |
| Gross profit | $688.0m | $736.6m | $688.1m | $639.2m | $708.1m | $680.1m | $696.9m | $681.8m |
| Operating income | $123.3m | $172.7m | $159.6m | $96.3m | $163.0m | $131.1m | $144.1m | $162.3m |
| Net income | $108.3m | $112.8m | $135.8m | $56.8m | $124.6m | $93.2m | $103.8m | $116.0m |
| Diluted earnings per share | 1.51 | 1.57 | 1.89 | 0.79 | 1.74 | 1.30 | 1.39 | 1.56 |
| Cash from operations | $192.0m | $151.0m | $223.0m | $188.0m | $128.0m | $52.0m | $286.0m | $263.0m |
| Capital spending | −$30.0m | −$30.0m | −$66.0m | −$66.0m | −$25.0m | −$25.0m | −$22.0m | −$29.0m |
| Free cash flow | $162.0m | $121.0m | $157.0m | $122.0m | $103.0m | $27.0m | $264.0m | $234.0m |
| Total assets | $6.4m | $6.31bn | $6.23bn | $6.23bn | $6.22bn | $6.10bn | $6.21bn | $6.37bn |
| Cash and short-term investments | $1.1m | $1.06bn | $1.09bn | $1.00bn | $901.2m | $873.0m | $1.04bn | $1.04bn |
| Debt | $34,224 | $32.6m | $31.9m | $34.0m | $32.5m | $32.0m | $31.1m | $31.2m |
| Shareholders' equity | $4.2m | $4.15bn | $4.05bn | $3.96bn | $3.91bn | $3.79bn | $3.85bn | $3.94bn |
Financial ratios
Data as of 2 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2017 | |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 68.3% | 70.0% | 70.1% | 70.5% | 74.3% | 71.3% | — | — |
| Operating margin | 15.3% | 15.2% | 16.7% | 17.2% | 24.7% | 15.7% | — | — |
| Net margin | 10.2% | 10.5% | 11.5% | 9.7% | 19.5% | 71.8% | — | — |
| Return on equity | 10.1% | 10.9% | 12.3% | 10.0% | 21.3% | 54.9% | — | — |
| Return on assets | 6.6% | 6.8% | 7.3% | 6.1% | 13.0% | 36.8% | — | — |
| Free cash flow yield | 6.7% | 7.9% | 8.7% | 7.6% | 13.6% | 7.1% | — | — |
| Revenue growth | 0.9% | 3.5% | 3.4% | -5.5% | 59.9% | 2.7% | — | — |
| Earnings growth | -2.6% | -5.3% | 23.1% | -53.2% | -56.5% | 301.1% | — | — |
| Current ratio | 1.36x | 1.22x | 1.18x | 1.26x | 1.30x | 1.40x | — | — |
| Debt to equity | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | — | — |
| Equity ratio | 65.0% | 62.0% | 59.7% | 60.5% | 61.0% | 67.0% | — | — |
| Interest coverage | — | — | 301.47x | 119.73x | 27.10x | 47.09x | 3.67x | 31.61x |
| R&D as a share of sales | 9.2% | 9.1% | 9.0% | 8.2% | 6.3% | 7.1% | — | — |
| Buybacks as a share of market value | 3.6% | 1.8% | 2.4% | 2.2% | 0.1% | -0.5% | — | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 2.6% | 10.3% | 16.9% |
| Operating income | -1.4% | 9.7% | 12.6% |
| Net income | 4.3% | -25.4% | 11.0% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 69.2% | 69.7% | 70.7% | 71.6% |
| Operating margin | 15.2% | 16.1% | 17.6% | 19.0% |
| Net margin | 10.4% | 10.5% | 19.0% | 18.8% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 27.3 | 23.4 | 29.6 | 28.7 | 42.9 | 15.2 | 31.6 | 26.8 | 49.8 | 26.2 |
| Price to sales | 2.8 | 2.5 | 3.4 | 2.8 | 8.4 | 10.9 | 5.8 | 5.5 | 7.8 | 4.6 |
Market value over time
30 Nov 2016 to 1 Oct 2026, in USD
$7.58bn$10.41bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | 20% | -21% | 35% | -67% | 12% | 94% | 38% | -15% | 135% | 55% |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.